V
Viol Co Ltd
KOSDAQ:335890
Viol Co Ltd
KOSDAQ:335890
Price:
12 500
KRW
Market Closed
Market Cap:
₩730.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
KR |
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
|
Samudera Indonesia Tbk PT
IDX:SMDR
|
ID |
Multiples-Based Value
The Multiples-Based Value of one Viol Co Ltd stock under the Base Case scenario is 7 644.73 KRW. Compared to the current market price of 12 500 KRW, Viol Co Ltd is Overvalued by 39%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Multiples-Based Value
Base Case
7 644.73
KRW
Overvaluation 39%
V
Multiples Across Competitors
Competitors Multiples
Viol Co Ltd Competitors
Viol Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
V
|
Viol Co Ltd
KOSDAQ:335890
|
721.8B KRW | 11.8 | 24.9 | 17.2 | 18.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.6B USD | 4.1 | 27.8 | 15.9 | 21.9 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.4B USD | 16.5 | 58.3 | 44.1 | 54.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.3B USD | 5.1 | 39.2 | 20 | 24.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.5B USD | 3.2 | 24.4 | 13.5 | 19.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
104.1B USD | 5.2 | 35.9 | 21.1 | 28.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41B EUR | 1.8 | 19.4 | 10.9 | 15.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.7B USD | 7.9 | 44.4 | 24.4 | 26.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.7B USD | 10.6 | 43.1 | 30.6 | 33.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.8B USD | 2 | 25.5 | 10.1 | 17 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.4B USD | 6 | 21.8 | 15.3 | 17 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
